Sutro Biopharma (STRO) Other Non Operating Income (2017 - 2018)
Sutro Biopharma (STRO) posted Other Non Operating Income of $1.1 million for Q4 2018, up 1677.94% sequentially from -$68000.0 in Q3 2018, and up 794.17% YoY from $120000.0 in Q4 2017.
Powered by 
Analysis
Sutro Biopharma (STRO) Other Non Operating Income (2017 - 2018) Analysis & Trends
Sutro Biopharma has reported Other Non Operating Income for 2 years, with the latest figure at $1.1 million in Q4 2018.
- Quarterly Other Non Operating Income rose 794.17% year-over-year to $1.1 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $945000.0 (changed N/A YoY) and the FY2025 annual result came in at $148000.0, changed N/A from the prior year.
- Other Non Operating Income rose to $1.1 million in Q4 2018 per STRO's latest filing, from -$68000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $1.1 million in Q4 2018 and troughed at -$180000.0 in Q3 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Sutro Biopharma | 334.33 Mn | 169.99 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2018 | 1.07 Mn |
| Sep 30, 2018 | -68,000.00 |
| Dec 31, 2017 | 120,000.00 |
| Sep 30, 2017 | -180,000.00 |